Healthcare is a trillion-dollar industry in America alone, and the opportunities for investors to profit from it are absolutely incredible. However, the complexity of technical information (i.e., hard to pronounce drug names) and significant downside risks (i.e., failing an FDA approval) have led many investors to avoid the space entirely.
In the following video, Rule Breakers analyst Simon Erickson and healthcare analyst Michael Douglass introduce three fast-growing healthcare companies that don't require a PhD to decipher. Veeva Systems (NYSE:VEEV) is optimizing the way new drugs are brought to market, Athenahealth (NASDAQ:ATHN) is making hospitals more efficient, and Catamaran (UNKNOWN:CTRX.DL) is bringing down costs of the entire healthcare system. In the video, our analysts reveal what they believe makes each of these businesses so special.
Michael Douglass owns shares of Athenahealth. Simon Erickson owns shares of Catamaran and Veeva Systems. The Motley Fool recommends Athenahealth, Catamaran, and Veeva Systems. The Motley Fool owns shares of Catamaran. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.